TY - JOUR
T1 - Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation
AU - Toor, Jaspreet
AU - Adams, Emily R
AU - Aliee, Maryam
AU - Amoah, Benjamin
AU - Anderson, Roy M.
AU - Ayabina, Diepreye
AU - Bailey, Robin
AU - Basáñez, Maria-Gloria
AU - Blok, David J.
AU - Blumberg, Seth
AU - Borlase, Anna
AU - Rivera, Rocio Caja
AU - Castaño, María Soledad
AU - Chitnis, Nakul
AU - Coffeng, Luc E.
AU - Crump, Ronald E.
AU - Das, Aatreyee
AU - Davis, Christopher N.
AU - Davis, Emma L.
AU - Deiner, Michael S.
AU - Diggle, Peter J.
AU - Fronterre, Claudio
AU - Giardina, Federica
AU - Giorgi, Emanuele
AU - Graham, Matthew
AU - Hamley, Jonathan I. D.
AU - Huang, Ching-I
AU - Kura, Klodeta
AU - Lietman, Thomas M.
AU - Lucas, Tim C. D.
AU - Malizia, Veronica
AU - Medley, Graham F.
AU - Meeyai, Aronrag
AU - Michael, Edwin
AU - Porco, Travis C.
AU - Prada, Joaquin M.
AU - Rock, Kat S.
AU - Le Rutte, Epke A.
AU - Smith, Morgan E.
AU - Spencer, Simon E. F.
AU - Stolk, Wilma A.
AU - Touloupou, Panayiota
AU - Vasconcelos, Andreia
AU - Vegvari, Carolin
AU - de Vlas, Sake J.
AU - Walker, Martin
AU - Hollingsworth, T. Deirdre
PY - 2020/9/28
Y1 - 2020/9/28
N2 - Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.
AB - Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.
UR - http://dx.doi.org/10.1093/cid/ciaa933
U2 - 10.1093/cid/ciaa933
DO - 10.1093/cid/ciaa933
M3 - Article
SN - 1058-4838
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
ER -